SymBiosis
Jennifer Miller is a highly experienced professional working as the COO & Board Member at a Stealth Biotech Startup focusing on engineering genetic medicines. Jennifer also serves as an Operating Advisor at SymBiosis, a Venture Capital firm specializing in treatments for serious human diseases. Additionally, Jennifer holds various advisory roles at academic institutions and has a background in corporate development, strategy, and technology in the biotech industry.
This person is not in any teams
SymBiosis
SymBiosis is an investment firm focused on advancing biotherapeutics innovations for serious and life-threatening diseases. The firm invests in groundbreaking medicines across disease area, financing stage, and geography, with a focus on programs in, or about to enter, human trials. SymBiosis currently manages a portfolio of more than 30 investments and has significant, long-term capital commitments to fund future investments.